Completed NA INTERVENTIONAL 1-arm NCT01366118

Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients (TT)

Prospective Pilot Study of Therapeutic Targets (TT) Tailored Chemotherapy (Ch) and Intensity Modulated Radiotherapy (IMRT) as Neoadjuvant Treatment in Patients With Rectal Carcinoma

Sponsor: Grupo Hospital de Madrid

Conditions Rectal Cancer

Interventions Therapeutic target tailored chemotherapy

Updated 5 times since 2017 Last updated: Jun 2, 2011 Started: Oct 31, 2009 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01366118, this NA trial focuses on Rectal Cancer and remains completed. Sponsored by Grupo Hospital de Madrid, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grupo Hospital de Madrid

Data source: Grupo Hospital de Madrid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain